|Day Low/High||4.92 / 5.10|
|52 Wk Low/High||4.58 / 12.53|
Bank of America lifts its price target on Cronos to $20 from $13.
During the week, we exited our position in KushCo Holdings and initiated Antares Pharma.
The FDA will discuss the safety and product quality of CBD-derived compounds in a public hearing Friday.
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
The company's announcement comes ahead of an FDA's public hearing on the legalization of CBD-infused foods and beverages on Friday.
Several positive moves along with our cash position helped insulate the overall portfolio’s performance from last week's market decline.
Aurora Cannabis has reached an agreement with the UFC to study the effect of CBD-infused products on athlete recovery and wellness; we also glance at J.C. Penney post-earnings.
The partnership is a multi-year, multi-million dollar global research partnership that looks to establish a link between CBD products and athlete wellness and recovery.
Multi-Year Global Partnership will Advance Science on Athlete Health and Wellness NYSE: ACB TSX:ACB EDMONTON, May 21, 2019 /PRNewswire/ - Aurora Cannabis Inc.
Amid renewed trade and geopolitical tensions, we trimmed our position in Energy Recovery and added a short-term trade in J.C. Penney.
Gainers trail losers in Cannabis sector action Thursday.
Gainers lead losers a day after financial results from Aurora and Tilray.
Stocks end higher following a report that the Trump administration plans to delay auto tariffs for six months.
Energy Recovery has stabilized above our target, warranting some action. Plus, Aurora Cannabis reports earnings.
Aurora Cannabis is well off the lows, but not posting a very big move on earnings. Here are the must-know breakout and breakdown levels to watch.
Action Alerts Plus senior analyst Jeff Marks has some advice for investors looking to invest in cannabis and what they should be watching.
Curious about the cannabis sector? Here's what Tilray and Aurora's earnings mean for the sector.
Is the market oversold? What should investors need to know about Tilray, Aurora and Macy's earnings? Here's what investors need to know according to Action Alerts Plus senior analyst Jeff Marks and Real Money reporter Kevin Curran.
It's time to tackle the markets, and earnings from Macy's, Tilray and Aurora. Join Katherine Ross, Jeff Marks and Kevin Curran as they discuss the biggest market headlines.
Tilray shares traded higher Wednesday after the Canadian cannabis group posted stronger-than-expected first quarter sales, while its domestic rival Aurora Cannabis slumped after its revenues missed analysts' forecast amid caps on retail store growth in the Canadian market.
U.S. stock futures decline though sentiment gets a lift from a softening of the rhetoric from Donald Trump in the U.S.-China trade war; Cisco, Alibaba and Macy's report earnings; Tilray shares rise after the Canadian cannabis company posts a revenue beat.
Canadian cannabis producer says loss attributable to shareholders was C$158 million.
Solid Net Revenue Growth Across All Channels to $65.1 Million Production Volumes Double While Per-Unit Production Costs Decline On Track to Deliver Positive EBITDA Beginning in Fiscal Q4 2019 TSX: ACB | NYSE: ACB EDMONTON, May 14, 2019 /PRNewswire/...
U.S. stock futures point to a modest rebound for Wall Street on Tuesday after markets reeled in the previous session as China retaliated in its trade war with the U.S.; Bayer's Monsanto loses $2 billion verdict in Roundup cancer trial; Walmart takes on Amazon with free, next-day delivery.
We took some nice profits trimming a position, exited a name and added to another holding during a challenging week for stocks.
Aurora Cannabis shares are falling ahead of the release of the cannabis company's earnings report Tuesday.
Transformational Milestone for Radient, Increasing Aurora's Global Derivative Market Capacity Substantially TSX: ACB | NYSE: ACB, TSXV: RTI EDMONTON, May 13, 2019 /PRNewswire/ - Aurora Cannabis Inc.
The markets staged a big reversal Friday after the China tariffs and Uber's IPO thud. Jim Cramer's got your game plan for next week.
Jim Cramer takes a look at ADT, Domo, Aurora Cannabis, Seaspan, Walgreens Boots Alliance, Sirius XM Radio and more.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.